Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.
Saved in:
| Title: | Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study. |
|---|---|
| Authors: | Takemoto, Shinnosuke1 (AUTHOR), Fukuda, Minoru1,2 (AUTHOR) mifukuda@nagasaki-u.ac.jp, Yamaguchi, Hiroyuki1 (AUTHOR), Ikeda, Takaya3 (AUTHOR), Akagi, Kazumasa4 (AUTHOR), Tomono, Hiromi5 (AUTHOR), Umeyama, Yasuhiro1 (AUTHOR), Dotsu, Yosuke1 (AUTHOR), Taniguchi, Hirokazu1 (AUTHOR), Gyotoku, Hiroshi6 (AUTHOR), Senju, Hiroaki1 (AUTHOR), Kitazaki, Takeshi7 (AUTHOR), Nakatomi, Katsumi8 (AUTHOR), Nagashima, Seiji6 (AUTHOR), Fukuda, Masaaki7 (AUTHOR), Kinoshita, Akitoshi4 (AUTHOR), Soda, Hiroshi5 (AUTHOR), Mukae, Hiroshi1 (AUTHOR) |
| Source: | Thoracic Cancer. Feb2020, Vol. 11 Issue 2, p389-393. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
